Introduction: Dual-biomarker positron emission tomography (PET), providing complementary information on cerebral blood flow and amyloid-b deposition, is of clinical interest for Alzheimer's disease (AD). The purpose of this study was to validate the perfusion components of early-phase 18 Fflorbetapir (eAV45), the 18 F-AV45 delivery rate (R1), and 18 F-FDG against
Introduction
Alzheimer's disease (AD) is a progressive, neurodegenerative disorder characterized by the presence of intracellular neurofibrillary tangles and extracellular amyloid-b (Ab) plaques in the brain [1] . These protein aggregates cause neuropathological changes, leading to synaptic and neuronal cell death, as well as progressive loss of cognitive function. While the accumulation of Ab plaques is believed to be one of the factors driving AD pathogenesis and is used for diagnostic workup, there is evidence that also vascular and metabolic factors are involved in the development and progression of AD [2] . Indeed, prior imaging studies have demonstrated brain patterns of reduced cerebral blood flow (CBF) and cerebral metabolic rates of glucose (CMRglc) as possible biomarkers of AD [3, 4] . Moreover, these markers were found to be particularly sensitive in predicting cognitive decline and conversion to AD dementia; therefore, they can be applied to identify clinical drug trial participants who are in a milder and earlier phase of the disease [5, 6] . In addition, because of their direct relationship with symptom severity, CBF and CMRglc patterns may be used to assess a therapeutic response in these trials [7, 8] .
The 15 O-H 2 O tissue concentration is known to be linearly related to CBF [9] . Hence, the gold standard for noninvasive measurement of CBF is 15 O-labeled H 2 O positron emission tomography (PET). However, the short decay time of 15 O limits its use in routine clinical practice and to sites with a cyclotron. Recent work has shown that the early time frames of dynamic 11 C-Pittsburgh compound B (PiB) PET are closely related to the first-pass influx rate (K1), the latter being strongly correlated to CBF because of a high extraction fraction of lipophilic radiotracers into the brain (K1 5 CBF ! extraction, with extraction z 77% for 11 C-PiB) [10, 11] . This is of clinical interest as perfusion may be derived from the earliest frames of the PET scan, whereas Ab burden can be measured at later times after injection, thereby combining functional and pathological information in one Ab-tracer PET protocol [12] . Alternatively, the ratio of K1 to its reference region value (i.e., delivery rate R1), serving as a measure of relative perfusion, can be derived together with the amyloid binding potential (BP ND ) from pharmacokinetic modeling of one dynamic amyloid-PET scan [13] . Our group previously validated the R1 of 18 F-florbetapir ( 18 F-AV45) against the standardized uptake value ratio (SUVR) of 15 O-H 2 O PET in the AD spectrum [14] . Indeed, 18 F-AV45 is known to be lipophilic (Moriguchi logP 2.52 [15] ) and thus to have good extraction into the brain. However, R1 was based on dynamic scanning with arterial cannulation and labor-intensive metabolite analysis. No studies have yet validated 18 F-AV45-R1 based on the (two-step) simplified reference tissue model (SRTM2) [16] [12, [17] [18] [19] [20] [21] [22] [23] . A dual-biomarker scan may thus provide information on both Ab pathology and neuronal injury/neurodegeneration and ultimately circumvent the need for an additional 18 F-FDG scan in the dementia workup [21] . Such an approach would be highly useful in the clinic as it results in decreased costs, less radiation exposure, and more patient comfort [12, 24] . In this study, we investigated the association between CBF and CMRglc distribution by comparing 18 F-FDG PET directly to 15 O-H 2 O PET in sporadic AD and how these markers associate with cognition.
In conclusion, the main objectives of this work were three-fold: (1) determine the optimal early time frame of 18 F-eAV45 in association with 15 O-H 2 O PET; (2) evaluate the perfusion components of 18 F-eAV45, SRTM2-based R1, and 18 F-FDG in comparison to 15 O-H 2 O data; and (3) investigate how these measures relate with clinical diagnosis and cognition. All analyses investigated the impact of the most widely used reference regions for these tracers: cerebellar gray matter (CB) and pons for 18 F-FDG quantification, and CB and subcortical white matter (WM) for 18 F-AV45 quantification.
Methods

Study population
Thirty-nine subjects were enrolled in the study, including 10 healthy controls (HCs), 19 amnestic mild cognitive impairment (aMCI) subjects, and 10 AD dementia subjects. Their demographics are shown in [25] . Categorization into diagnostic groups was made on a demographical and clinical basis by obtaining consensus from three expert medical doctors. Clinical diagnoses of "MCI due to AD" (MCI) and "dementia due to AD" (AD dementia) were based on the criteria of the National Institute on Aging and Alzheimer's Association [26, 27] . A description of inclusion and exclusion criteria can be found in the study by Niemantsverdriet et al. [28] . Patients were recruited through the Memory Clinic of ZNA Middelheim and Hoge Beuken, Antwerp, Belgium. Cognitively healthy elderly consisted of volunteers, mainly spouses of patients who visited the memory clinic.
Approval for the study was obtained from the Committee for Medical Ethics of the University of Antwerp/University Hospital Antwerp (14/12/130) and of Hospital Network Antwerp (ZNA) (4310), and all procedures were performed in accordance with the Helsinki Declaration of 1975. All participants or their representatives provided written informed consent.
Image acquisition and analysis
Procedures for acquisition of PET and magnetic resonance images and radiometabolite analysis are described elsewhere [14] . Briefly, 3D T1-weighted magnetizationprepared rapid acquistion gradient-echo scans were obtained on a Siemens Trio Tim 3T magnetic resonance scanner with 1-mm isotropic voxels. 18 F-AV45 was injected as an intravenous bolus of 291 6 66 MBq, and 60-min dynamic scanning was performed on a Siemens Biograph mCT time-of-flight PET scanner. Simultaneously with the dynamic AV45 PET acquisition, 60-min continuous arterial blood sampling (Twilite; Swisstrace, Switzerland) and manual sampling at discrete time points was performed to derive the metabolite-corrected plasma input function for each subject. Time-weighted averaging of the early frames of the dynamic AV45 scans between the start time (T1 5 0, 30, or 60 s) and end time (T2 5 1, 2, 3, 4, or 6 min) after injection was performed in PMOD (PMOD Technologies Ltd., Zurich, Switzerland) to generate an array of potential eAV45 images. The time-weighted averaging method was first validated against the reconstruction of the list-mode AV45 dynamic data into a single frame. For the first 6 min of AV45, correlations between resulting SUVRs of both methods were as high as 0.99 (Pearson r). Therefore, the time-weighted averaging method was used to determine eAV45 images in this manuscript. Dynamic H 2 O (370 MBq) and static FDG (153 6 18 MBq) images were acquired at 0-2 min and 30-40 min after injection, respectively. Time interval between PET acquisitions within one subject was minimal (AV45 vs. H 2 O: 24 6 180 days, vs. FDG: 24 6 181 days, vs. MRI: 22 6 77 days).
Interframe motion correction of the dynamic PET scans and PET-to-MRI coregistration were performed for each subject separately using PMOD v3.6 (PMOD Technologies Ltd., Zurich, Switzerland). The eAV45 and R1 PET-to-MRI coregistration was based on the first 2-min and the 60-min data, respectively. Regions of interest (ROIs) were delineated using automated knowledge-based "gray matter/WM/cerebrospinal fluid" segmentation of each subject's MRI and the Automated Anatomical Labeling atlas in PMOD. ROIs included the cortical gray matter target regions (the four cortical lobes, anterior cingulate cortex, posterior cingulate cortex [PCC], precuneus), the hippocampus target region, and the reference regions CB, whole subcortical WM, and pons. PET timeactivity curves were extracted in the different ROIs and corrected for partial volume effects based on the region-based geometric transfer matrix method [29] and a 5 ! 5 ! 5-mm 3 PET scanner resolution. Regional H 2 O, eAV45, and FDG were quantified as SUVR at 0-1 min, T1-T2 min, and 30-40 min after injection, respectively. Regional R1 values were derived from 2-tissue compartment modeling (2TCM4k_Vb) of the dynamic AV45 images and metabolite-corrected plasma input functions [14] . Alternatively, R1 was computed based on SRTM2 with fixed k2' using a coupled fit across the target ROIs. SRTM2 was chosen over SRTM as the former model has been shown to reduce noise [16] . The CB and pons were applied as reference regions for FDG SUVR, whereas CB and WM were applied as reference regions for eAV45 SUVR and R1. H 2 O SUVR was considered as the gold standard to measure CBF using CB, pons, or WM as the reference region.
Voxel-wise AV45-R1 maps were generated using PXMOD v3.3 with SRTM2 and a fixed subject-specific k2' extracted from the regional kinetic modeling toolbox (PKIN). All CBF maps were normalized and averaged per tracer and diagnostic group to compare their spatial patterns.
Statistical analysis
Statistical analyses were performed in IBM SPSS Statistics v24. Demographical differences among diagnostic groups were assessed using Fisher's exact tests for categorical variables and Kruskal-Wallis tests with Bonferroni correction for continuous variables. The optimal early time frame of eAV45 was determined when the highest correlation (Pearson r) between eAV45 (T1,T2) and H 2 O SUVRs was achieved. Furthermore, Pearson r was used to assess correlations between all CBF measures, as well as to assess partial correlations between CBF and cognitive scores corrected for age and education. All correlative analyses were corrected for multiple comparisons (number of ROIs) using Bonferroni at P , .05, .01, .001, and .0001 and included all subjects. To compare differences in CBF patterns between the diagnostic groups, voxel-wise analyses of covariance (P , .05 corrected for age and education, cluster extent 50 voxels) were performed in SPM12 (Wellcome Department of Cognitive Neurology, London, UK) implemented in MATLAB 2017 (The Mathworks, Sherborn, MA, USA). Finally, receiver operating characteristic area under the curve (AUC) analyses were applied on regional CBF measures to compare their discriminative ability for classification of patients with aMCI/AD dementia from HCs.
Results
Reference regions
The SUV and K1 values of the pons, CB, and WM-representing the blood flow in the reference regions-did Table 1 ). Within one CBF measure and diagnostic group, the coefficient of variation was similar across reference regions.
Validation of SRTM2-based R1
The AV45 delivery rate R1 derived from the 2TCM was strongly correlated with R1 from SRTM2. For reference CB, correlation coefficients were as high as 0.98 -0.99 (P , .0001) in the target regions, except for the PCC (r 5 0.94, P , .0001). For reference WM, correlation coefficients were slightly lower, ranging from 0.78 in the temporal lobe to 0.95 in the PCC and hippocampus (P , .0001). R1 based on the SRTM2 was used in all further analyses.
Optimization of early time frame of eAV45
To optimize the early time frame for eAV45, correlation plots of different early time frames of AV45 (start time T1 5 0, 30, or 60 s; end time T2 5 1, 2, 3, 4, or 6 min) versus H 2 O SUVR (and for completeness, vs. AV45-R1 as well) are shown in Fig. 1 . Pearson r was highest when the time frame of 0-2 min was selected for eAV45. Excluding the first 30 s from the early phases (black curves) gave similar results as starting at 0 s; however, excluding the first 60 s resulted in lower correlation coefficients (red curves). As a result, eAV45 (0-2 min) was used in further analyses as a proxy of CBF.
CBF proxies versus H 2 O PET
Among all relative CBF proxies, the early-phase SUVR CB Fig. 1 ).
Absolute measures representing global CBF showed, in general, weak correlations with H 2 O SUV (Pearson r , 0.7) ( Table 2 ). Correlations of H 2 O SUV with the AV45 delivery rate K1 reached significance in all regions (Pearson r ranging from 0.44 in the parietal lobe to 0.68 in the PCC, P , .006), whereas correlations with FDG SUV were significant only in the precuneus and PCC (r 5 0.44 and 0.45, respectively, P , .006). eAV45 and H 2 O SUV were significantly correlated only in the PCC (r 5 0.54, P , .001).
CBF versus clinical diagnosis and cognition
Group-averaged images of the four CBF proxies normalized to CB are shown in Fig. 2 ; group-averaged images with Fig. 1 . Within-subject correlations of early-phase AV45 SUVR with H 2 O SUVR (circles) and AV45-R1 (squares) using the precuneus (A) or the PCC (B) as the target region and the CB (left) or the WM (right) as the reference region. The early-phase time frames were T1 and T2, with T1 being 0, 30, or 60 sec (blue, black, and red curves, respectively) and T2 being 1, 2, 3, 4, or 6 min (X-axis). For the blue curves, the 95% confidence intervals of the correlations are shown as well. Abbreviations: eAV45, early-phase AV45; PCC, posterior cingulate cortex; SUVR, standardized uptake value ratio. alternative reference regions were visually similar. Voxelwise analyses revealed that the CBF was significantly reduced in the precuneus/PCC area of both patients with aMCI and those with AD dementia compared with HCs (P , .05 corrected for age and education, cluster extent 50 voxels) (Fig. 3) . Other regions of significant CBF reduction included the frontal and parietotemporal lobe and the hippocampus. Remarkably, eAV45 SUVR underestimated CBF reductions compared with R1 and was less closely related to FDG patterns (Figs. 2 and 3) . The eAV45 and R1 reductions with a WM reference followed better the disease progression than with a CB reference region (Fig. 3A vs. 3B) . Based on the regional group comparisons, all CBF measures were significantly lower in both patients with aMCI and AD dementia than those in HCs in the PCC (w220%; Table 3 and Supplementary  Table 2 ). FDG SUVR pons was additionally reduced in the hippocampus (b 5 20.36, P 5 .03) and precuneus (b 5 20.45, P 5.02) in patients with AD dementia, whereas R1 WM showed a trend (b 5 20.29 and 20.34, P 5 .06 and .08, respectively). eAV45 showed smaller effect size (i.e., standardized b) than R1, whereas FDG showed the highest effect sizes (Table 3) .
Irrespective of CBF measure and reference region, reduced CBF in the PCC was significantly (P , .025) corre- (Table 4 ). The associations were most strongly driven by the aMCI and HC groups (Supplementary Fig. 2 ). In addition, there were significant associations between reduced MMSE and CBF in the precuneus when applying a WM reference region for eAV45 and R1 (Table 4) . Correlation coefficients were weaker for eAV45 than for R1. Table 3 ). In addition, FDG SUVR pons could discriminate between HCs and patients with AD dementia in the frontal, temporal, and parietal lobe; precuneus; and hippocampus (AUC 5 0.76-0.88). When the WM reference region was applied, the R1 and eAV45 measures could discriminate HCs from patients with aMCI and AD dementia also in the hippocampus (AUC 5 0.73-0.87).
CBF proxies versus FDG PET
The optimal early time frame for eAV45 in relation to FDG SUVR was also 0-2 min (Supplementary Fig. 3 ). Both the early-phase (0-2 min) SUVR CB and R1 CB of AV45 were strongly associated with FDG CB (Pearson r ranging from 0.53 and 0.55 [occipital lobe] to 0.81 and 0.85 [hippocampus], respectively; P , .001) (Supplementary Table 4 ). Correlations between absolute measures were weaker.
Discussion
The present study showed that the FDG and AV45 (earlyphase SUVR and SRTM2-based R1) indices were well correlated with the gold standard H 2 O SUVR and may therefore serve as proxies of CBF. The within-subject correlations between R1 and eAV45 were likewise very high, indicating that the first 2 min of a dynamic AV45 scan-representing first-pass extraction of the tracer-can be representative for perfusion. Both the early phases and R1 of AV45 are of clinical interest as amyloid-PET tracers benefit from the ability to provide information on both CBF (early phase) and Ab burden (late phase) in one imaging session [12, 24] . This may increase diagnostic accuracy and accelerate treatment initiation and clinical trial referral, while avoiding the increased radiation exposure and medical costs associated with an additional FDG scan. One may advocate that the use of eAV45 SUVR should be chosen over R1 because it avoids long dynamic scanning with labor-intensive kinetic modeling. However, in the present study, eAV45 SUVR tended to underestimate CBF reduction, was more weakly correlated to cognition, and showed lower discriminative ability in the hippocampus, precuneus, and PCC than R1. This may be related to a biased PET-to-MRI coregistration when using only the early-phase data compared with 60-min fulldynamic data. We suggest R1 as a more robust representation of CBF than the early phases. This study reports for the first time associations between cognition and CBF in cases of sporadic AD using the gold standard measurement H 2 O, with supporting data using R1, eAV45, and FDG. We found that reductions in all four measures were significantly correlated with lower MMSE and (immediate and delayed) memory index scores, but they were significant only in the PCC after correction for multiple comparisons and the covariates age and education. In addition, FDG and eAV45/R1 WM showed significant correlations with MMSE in the precuneus. Previous studies have mainly focused on associations with MMSE and found significant results in the PCC/precuneus as well as in the parietotemporal association cortices [18, 19, 22, 30] . With regard to discriminative ability, we found that all four CBF markers could significantly discriminate between HC and AD dementia in the PCC. In addition, FDG SUVR pons could discriminate in the frontal, parietotemporal, hippocampus, and precuneus areas. Other studies also found FDG to be slightly superior to other CBF markers in discriminating AD dementia or MCI Ab1 from controls [20] and PiB1 from PiB- [12] . Distinct findings between CBF and CMRglc distribution markers might be explained by the fact that reduced uptake on FDG not only represents impaired CBF but also neuronal dysfunction. Although we and others have reported a significant overlap between both markers in the bilateral parietotemporal lobes, precuneus, and PCC [31] , a regional neurovascular decoupling is present in the resting brain [32] as well as in the earlier stages of disease progression [20, 33] . We demonstrated that hypometabolic patterns extended over wider brain areas and became stronger with disease severity than patterns of hypoperfusion. Moreover, correlations between FDG and H 2 O uptake values were region-dependent, being weak in the frontal and occipital lobe. Increased CBF in these regions has been hypothesized to reflect a vascular compensatory mechanism for reduced metabolism [34] . Therefore, although R1, eAV45, and FDG images can be used to represent tissue CBF, FDG remains the measure of choice for quantifying neuronal and synaptic function. Future studies should evaluate whether CBF proxies can replace FDG images on a single-subject level for clinical purposes, for example, to discriminate AD from non-AD dementias [21] .
Head-to-head comparison between early-phase SUVR and R1 of AV45, in terms of regional correlation strength to FDG SUVR, showed similar results. Previous studies likewise compared R1 to the early phases of PiB [35, 36] and AV45 [17] in relation to FDG, reporting comparable correlation strength and discriminative ability for both measures. Other literature has merely focused on the relationship between early-phase amyloid and FDG PET alone and reported Fig. 3 . T-maps showing significantly reduced CBF in aMCI (n 5 19) and AD dementia (n 5 10) versus HC (n 5 10) in the frontal lobe, parietal lobe, precuneus/ PCC (horizontal slice, white arrows); the frontal lobe, precuneus/PCC (sagittal slice, white arrows); the temporal lobe and hippocampus (coronal slice, white arrows). Panel (A) shows the results when CB normalization was applied, whereas panel (B) shows the results for alternative reference regions (i.e., WM for AV45 and H 2 O, pons for FDG). A mask was applied around the ventricles because of spillover and enlargement of ventricles in aMCI/AD dementia. P , .05 corrected for age and education, cluster extent 50 voxels. Abbreviations: AD, Alzheimer's disease; aMCI, amnestic mild cognitive impairment; CB, cerebellar gray matter; CBF, cerebral blood flow; eAV45, early-phase AV45; HC, healthy control; PCC, posterior cingulate cortex; WM, white matter.
good correlations (e.g., in PCC/parietal cortex, ePiB vs. FDG: r 5 0.74 [12] ; eFBB vs. FDG: r 5 0.82-0.92 [21] ; eAV45 vs. FDG: r 5 0.80-0.86 [17] ). The latter study by Hsiao et al. [17] suggested to extend the integration time from the first 2 min to the first 6 min to improve the associations with FDG. In contrast, we have shown that the 0-to 2-min interval for eAV45 was sufficient in comparison to both regional H 2 O and FDG values. Discrepancies between both studies may arise from a different sample size (39 vs. 7 in the study by Hsiao et al. [17] ) and partial-volume-corrected results (vs. noncorrected in the study by Hsiao et al. [17] ). Furthermore, we found similar pattern of results in group contrast using all CBF measures except eAV45; therefore, we suggest R1 as a closer proxy of perfusion and synaptic function. These findings are in line with recent crosssectional [37] and longitudinal [38] 11 C-PiB studies, comparing the early phases and R1 to FDG and/or H 2 O PET. Nevertheless, compared with eAV45, R1 has the disadvantage of requiring a dynamic scanning protocol and would therefore only be advised in clinical research settings in which high accuracy is needed (e.g., longitudinal or therapy-monitoring studies). On the other hand, methods such as simultaneous ASL-MRI and amyloid-PET or pharmacokinetic modeling of a noninvasive dual-time-window acquisition (two short dynamic scans capturing respectively the peak [early phase] and the tail [late phase] without acquiring the central portion of the time-activity curve) could be investigated as simplified alternatives to R1 as well.
Within-subject correlative analyses and intergroup voxelwise analyses were dependent on reference region selection. CB was used as a reference region in this study because of its low susceptibility to age-related atrophy and changes in metabolism and CBF [39, 40] . WM was applied as an alternative reference region for (early-phase and R1) AV45 measures, as recent studies have shown its use in accurately quantifying Ab plaque load [14] . On the other hand, for FDG PET, we selected the pons as an alternative reference region based on previous literature [41] . To the best of our knowledge, this is the first study investigating different reference regions for FDG, eAV45, and R1 in relation to H 2 O data. First, we found that SRTM2-based R1 was more strongly correlated to the reference standard 2TCM-based R1 when using CB instead of WM as the reference NOTE. for eAV45 SUVR, the 0-2 min frame was used (see Fig. 1 region. This might be explained by a significant (P , .0001) greater violation of one of the SRTM2 assumptions when WM normalization was applied, namely that the nonspecific K1/k2 in the target should equal the (nonspecific) V T in the reference, assuming both regions fit a 2TCM. In line with this, R1 CB was more strongly associated to H 2 O SUVR than R1 WM . Second, in relation to disease severity, aMCI but not AD dementia showed the strongest reduction in perfusion compared with HC, both for eAV45 SUVR and R1 normalized to CB. When using a WM reference region instead, perfusion was the lowest in AD dementia as should be expected given the progression of disease. This discrepancy might be explained by a reduced blood flow in the CB of AD dementia compared with HC and MCI [14] , questioning its use as a reference region. Moreover, R1 WM was correlated stronger to cognitive impairment in the PCC and precuneus than R1 CB . Hence, WM normalization resulted in better correspondence of CBF patterns with disease severity. This is in line with recent amyloid-PET studies reporting more stable and more plausible (e.g., nondecreasing) longitudinal SUVR values when the reference region included WM [42, 43] .
Noteworthy is that CBF was measured with 15 O-H 2 O PET as the gold standard. Owing to its limited blood-brain barrier permeability (extraction factor z 90-95%), 15 O-H 2 O PET may underestimate the true absolute CBF at elevated flow rates compared with the resting brain (.55 ml/min/100g) [44] . Another limitation of the study includes the relatively small sample size, which did not allow performing a multiple comparison correction at the voxel level. However, the main goal of this study was to compare correlation findings among PET modalities rather than to establish correlation patterns. Finally, different CBF PET modalities were not consistently recorded on the same day within one subject. Therefore, daily fluctuations in global CBF might explain why within-subject correlations between the absolute CBF measures were weaker than those between the relative measures.
Conclusion
The present study showed that the FDG and AV45 (earlyphase [0-2 min] SUVR and SRTM2-based R1) indices were well correlated with the gold standard H 2 O PET and may therefore serve as surrogate markers of CBF. In addition, we showed that all CBF measures were significantly reduced in the PCC of aMCI and AD dementia subjects and that these reductions were significantly associated with reduced cognitive scores. Both R1 and the early phases of AV45 are of clinical interest in case one wants to combine perfusion and Ab pathological information in one imaging session. Our study showed that R1 (especially using a WM reference region) better reflected the disease severity than did early-phase AV45 but has the disadvantage that a dynamic PET scan with pharmacokinetic modeling is required.
